Get started
Author

Virginija Danylaité Karrenbauer

Observed names: Karrenbauer, Virginija Danylaite, V. D. Karrenbauer, V. Karrenbauer, V.D. Karrenbauer, Virginija D. Karrenbauer, Virginija Danylaite Karrenbauer, Virginija Danylaitė Karrenbauer, Virginija Karrenbauer, Virginjia Danylaité-Karrenbauer
ORCID: 0000-0002-7166-8951
Observed ORCID: 0000-0002-7166-8951
OpenAlex ID: A5082228294
Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges
2022 · Jinming Han, Violeta Chitu, et al. · Cellular and Molecular Life Sciences · 161
PDF
Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development
2022 · Spyros Papapetropoulos, Angela Pontius, et al. · Frontiers in Neurology · 81
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
2016 · M. Vågberg, M. Axelsson, et al. · Acta Neurologica Scandinavica · 74
PDF
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients
2007 · Ádám Vas, Yevgeni Shchukin, et al. · Journal of the Neurological Sciences · 71
Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy
2020 · Jinming Han, Heela Sarlus, et al. · Acta Neuropathologica Communications · 65
PDF
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability
2017 · Andrius Kavaliunas, Virginija Danylaite Karrenbauer, et al. · Multiple Sclerosis Journal · 58
PDF
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy
2014 · Daniel Ferreira, Olga Voevodskaya, et al. · Journal of Neuroimmunology · 56
Increased levels of APRIL (A Proliferation-Inducing Ligand) mRNA in multiple sclerosis
2005 · Mathula Thangarajh, Thomas Masterman, et al. · Journal of Neuroimmunology · 51
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis
2014 · C. Sundal, M. Baker, et al. · European Journal of Neurology · 46
Plasma neurofilament light chain concentration is increased in anorexia nervosa
2019 · Ida A. K. Nilsson, Vincent Millischer, et al. · Translational Psychiatry · 41
PDF
Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function
2022 · Andrius Kavaliunas, Virginija Danylaitė Karrenbauer, et al. · Frontiers in Neurology · 39
Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study
2021 · Virginija Danylaité Karrenbauer, Sahl Khalid Bedri, et al. · Scientific Reports · 39
PDF
Neuroimaging phenotypes of CSF1R‐related leukoencephalopathy: Systematic review, meta‐analysis, and imaging recommendations
2021 · Goda‐Camille Mickeviciute, Monika Valiuskyte, et al. · Journal of Internal Medicine · 37
PDF
Socioeconomic consequences of multiple sclerosis—A systematic literature review
2021 · Andrius Kavaliunas, Virginija Danylaite Karrenbauer, et al. · Acta Neurologica Scandinavica · 37
PDF
Cognitive function predicts work disability among multiple sclerosis patients
2019 · Andrius Kavaliunas, Petter Tinghög, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 37
PDF
Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis
2005 · Virginija Danylaité Karrenbauer, Valerio Leoni, et al. · Clinical Neurology and Neurosurgery · 37
Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis
2015 · Lenka Novakova, Markus Axelsson, et al. · Journal of the Neurological Sciences · 28
Accurate classification of secondary progression in multiple sclerosis using a decision tree
2020 · Ryan Ramanujam, Feng Zhu, et al. · Multiple Sclerosis Journal · 27
Machine Learning and Multiparametric Brain MRI to Differentiate Hereditary Diffuse Leukodystrophy with Spheroids from Multiple Sclerosis
2020 · Gabriel Mangeat, Russell Ouellette, et al. · Journal of Neuroimaging · 24
PDF
Hereditary diffuse leukoencephalopathy with spheroids – a volumetric and radiological comparison with multiple sclerosis patients and healthy controls
2016 · T. Granberg, F. Hashim, et al. · European Journal of Neurology · 22
Increased Soluble 4‐1BB Ligand (4‐1BBL) Levels in Peripheral Blood of Patients with Multiple Sclerosis
2006 · G.‐z. Liu, A. C. Gomes, et al. · Scandinavian Journal of Immunology · 20
PDF
Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
2021 · Kyla A. McKay, Ronny Wickström, et al. · Scientific Reports · 15
PDF
Income in Multiple Sclerosis Patients with Different Disease Phenotypes
2017 · Andrius Kavaliunas, Ali Manouchehrinia, et al. · PLoS ONE · 15
PDF
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients
2012 · Virginija Danylaitė Karrenbauer, Robert Prejs, et al. · Journal of Neuroimmunology · 12
Four Swedish cases of CSF1R‐related leukoencephalopathy: Visualization of clinical phenotypes
2022 · Igal Rosenstein, Oluf Andersen, et al. · Acta Neurologica Scandinavica · 8
PDF
Works count: 60
Citation count: 1,128
H-index: 20
I10-index: 24
Year
Topic
Type